EPKINLY (epcoritamab-bysp)

**Product type:** Human Prescription Drug

**Active ingredient:** EPCORITAMAB

**Strength:** 4 mg/.8mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Genmab US, Inc.

**Marketing category:** BLA (BLA761324)

**Pharmacologic class:** Bispecific CD20-directed CD3 T Cell Engager [EPC], CD20-directed Antibody Interactions [MoA], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Cytochrome P450 Inhibitors [MoA], Increased Cytokine Activity [PE]